Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Prostatic Neoplasms 19Neoplasms 5Unspecified Adult Solid Tumor, Protocol Specific 2Glioma 2Glioblastoma 2Brain Neoplasms 2Thromboembolism 1Solid Tumors 1Oligodendroglioma 1Neuroblastoma 1Lymphoma, Follicular 1Leukemia, Myeloid, Chronic-Phase 1Granulosa Cell Tumor 1Castration-resistant Prostate Cancer 1Breast Neoplasms 1Astrocytoma 1Advanced Cancer 1

Interventions

Irinotecan 16Paclitaxel 14Docetaxel 13Gemcitabine 12Cisplatin 12Capecitabine 8Oxaliplatin 7Temozolomide 6Leucovorin 6Fluorouracil 6Carboplatin 6Topotecan 5Chromatography, High Pressure Liquid 5Polymerase Chain Reaction 4Pharmacogenomic Testing 4Pemetrexed 4Immunohistochemistry 4Filgrastim 4Everolimus 4Etoposide 4Early Intervention, Educational 4Celecoxib 4tipifarnib 3ixabepilone 3bryostatin 1 3Tegafur 3Sorafenib 3Mass Spectrometry 3Magnetic Resonance Spectroscopy 3Lapatinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Unspecified Adult Solid Tumor, Protocol Specific × Ketoconazole × Clear all
NCT00096317 2018-10-31

Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors

Montefiore Medical Center

Phase 1 Completed
29 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00238225 2013-01-31

Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors

Roswell Park Cancer Institute

Phase 1 Completed
15 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡